an 8 mg naloxone agent that is approved for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression. This six-year ...

Supervised induction: 8mg once on Day 1 and 16mg once on Day ... Maintenance phase: use buprenorphine/naloxone sublingual films at the same buprenorphine dose as Day 2; if intolerant to naloxone ...

Emergent (NYSE:EBS) already sells a 4mg naloxone nasal spray product under the brand name NARCAN. Under the six-year agreement, Hikma will continue to produce Kloxxado 8mg nasal spray.